These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15197660)

  • 21. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification by two genes of associations between general somatic health and incident depressive syndrome in older people.
    Kim JM; Stewart R; Kim SW; Yang SJ; Shin IS; Yoon JS
    Psychosom Med; 2009 Apr; 71(3):286-91. PubMed ID: 19251870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-induced depression: strategies in treatment.
    Asnis GM; De La Garza R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):808-18. PubMed ID: 15907352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people.
    Walderhaug E; Magnusson A; Neumeister A; Lappalainen J; Lunde H; Refsum H; Landrø NI
    Biol Psychiatry; 2007 Sep; 62(6):593-9. PubMed ID: 17544379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5HTTLPR polymorphism of the serotonin transporter gene is associated with affective temperaments as measured by TEMPS-A.
    Gonda X; Rihmer Z; Zsombok T; Bagdy G; Akiskal KK; Akiskal HS
    J Affect Disord; 2006 Apr; 91(2-3):125-31. PubMed ID: 16464506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior.
    Sawiniec J; Borkowski K; Ginalska G; Lewandowska-Stanek H
    Przegl Lek; 2007; 64(4-5):208-11. PubMed ID: 17724868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of depression: a review.
    Levinson DF
    Biol Psychiatry; 2006 Jul; 60(2):84-92. PubMed ID: 16300747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association study of serotonin system genes in childhood-onset mood disorder.
    Shaikh SA; Strauss J; King N; Bulgin NL; Vetró A; Kiss E; George CJ; Kovacs M; Barr CL; Kennedy JL;
    Psychiatr Genet; 2008 Apr; 18(2):47-52. PubMed ID: 18349694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME; Middlemas D; Bylund DB
    Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter and functional polymorphisms of HTR2C and suicide victims.
    Videtic A; Peternelj TT; Zupanc T; Balazic J; Komel R
    Genes Brain Behav; 2009 Jul; 8(5):541-5. PubMed ID: 19496825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1.
    Secher A; Bukh J; Bock C; Koefoed P; Rasmussen HB; Werge T; Kessing LV; Mellerup E
    Int Clin Psychopharmacol; 2009 Jul; 24(4):199-203. PubMed ID: 19474754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin transporter gene and response to lithium augmentation in depression.
    Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M
    Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk.
    O'Donovan C; Garnham JS; Hajek T; Alda M
    J Affect Disord; 2008 Apr; 107(1-3):293-8. PubMed ID: 17850879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the circadian timing systems: molecular mechanisms in mood disorders.
    Mendlewicz J
    CNS Drugs; 2009; 23 Suppl 2():15-26. PubMed ID: 19708722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intervention in the prevention psychiatric disorders in childhood].
    Solantaus T; Beardslee W
    Duodecim; 1996; 112(18):1647-56. PubMed ID: 10596157
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions.
    Lerer B; Macciardi F
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):255-75. PubMed ID: 12366879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics and pharmacogenetics of mood disorders.
    Serretti A
    Psychiatr Pol; 2017 Apr; 51(2):197-203. PubMed ID: 28581531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of antidepressant response.
    Keers R; Aitchison KJ
    Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics in the treatment of depression: pharmacodynamic studies.
    Serretti A; Artioli P; Quartesan R
    Pharmacogenet Genomics; 2005 Feb; 15(2):61-7. PubMed ID: 15861029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.